mebendazole has been researched along with Idiopathic Parkinson Disease in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gatto, M | 1 |
| Fernandez Pardal, M | 1 |
| Melero, M | 1 |
| Zurru, C | 1 |
| Scorticati, C | 1 |
| Micheli, F | 1 |
1 other study available for mebendazole and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
L-dopa malabsorption in a parkinsonian patient with Strongyloides stercoralis duodenitis.
Topics: Aged; Animals; Duodenitis; Humans; Intestinal Diseases, Parasitic; Levodopa; Male; Mebendazole; Metr | 1994 |